• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New symptom-based predictive tool for survival at seven and thirty days developed by palliative home care teams.姑息性家庭护理团队开发的基于新症状的7天和30天生存预测工具。
J Palliat Med. 2014 Oct;17(10):1158-63. doi: 10.1089/jpm.2013.0630. Epub 2014 Jun 12.
2
Prognostic factors of survival in patients with advanced cancer admitted to home care.晚期癌症患者接受家庭护理的生存预后因素。
J Pain Symptom Manage. 2013 Jan;45(1):56-62. doi: 10.1016/j.jpainsymman.2011.12.288. Epub 2012 Sep 24.
3
Patients attended by palliative care teams: are they always comparable populations?接受姑息治疗团队护理的患者:他们总是具有可比性的群体吗?
Springerplus. 2013 Apr 22;2(1):177. doi: 10.1186/2193-1801-2-177. Print 2013 Dec.
4
Prospective Validation of the Objective Prognostic Score for Advanced Cancer Patients in Diverse Palliative Settings.晚期癌症患者客观预后评分在不同姑息治疗环境中的前瞻性验证
J Pain Symptom Manage. 2016 Sep;52(3):420-7. doi: 10.1016/j.jpainsymman.2016.03.015. Epub 2016 Jul 4.
5
Development and external validation of a predictive multivariable model for last-weeks survival of advanced cancer patients in the palliative home care setting (PACS).开发并验证预测晚期癌症患者在姑息治疗居家环境下最后一周生存的多变量预测模型(PACS)。
Support Care Cancer. 2023 Aug 25;31(9):536. doi: 10.1007/s00520-023-07990-2.
6
Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study.姑息治疗研究预后(PiPS)预测模型的开发,以改善晚期癌症的预后:前瞻性队列研究。
BMJ. 2011 Aug 25;343:d4920. doi: 10.1136/bmj.d4920.
7
Multicenter cohort study on the survival time of cancer patients dying at home or in a hospital: Does place matter?多中心队列研究:在家中或医院死亡的癌症患者的生存时间:地点重要吗?
Cancer. 2016 May 1;122(9):1453-60. doi: 10.1002/cncr.29844. Epub 2016 Mar 28.
8
Objective palliative prognostic score among patients with advanced cancer.晚期癌症患者的客观姑息预后评分。
J Pain Symptom Manage. 2015 Apr;49(4):690-6. doi: 10.1016/j.jpainsymman.2014.08.017. Epub 2014 Sep 28.
9
Prognostication in Home-Dwelling Patients with Advanced Dementia: The Palliative Support DEMentia Model (PalS-DEM).居家晚期痴呆患者的预后预测:姑息支持痴呆模型(PalS-DEM)。
J Am Med Dir Assoc. 2021 Feb;22(2):312-319.e3. doi: 10.1016/j.jamda.2020.11.017. Epub 2020 Dec 13.
10
Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer.开发和验证一种基于患者报告结局的癌症患者预后生存模型。
JAMA Netw Open. 2020 Apr 1;3(4):e201768. doi: 10.1001/jamanetworkopen.2020.1768.

引用本文的文献

1
Machine learning applied to electronic health record data in home healthcare: A scoping review.机器学习在家庭医疗保健中的电子健康记录数据中的应用:范围综述。
Int J Med Inform. 2023 Feb;170:104978. doi: 10.1016/j.ijmedinf.2022.104978. Epub 2022 Dec 30.
2
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients.晚期癌症患者口腔黏膜炎、口干和吞咽困难的患病率。
Support Care Cancer. 2015 Nov;23(11):3249-55. doi: 10.1007/s00520-015-2720-y. Epub 2015 Apr 3.

本文引用的文献

1
Patients attended by palliative care teams: are they always comparable populations?接受姑息治疗团队护理的患者:他们总是具有可比性的群体吗?
Springerplus. 2013 Apr 22;2(1):177. doi: 10.1186/2193-1801-2-177. Print 2013 Dec.
2
Development and validation of a prognostic nomogram for terminally ill cancer patients.终末期癌症患者预后列线图的开发和验证。
J Natl Cancer Inst. 2011 Nov 2;103(21):1613-20. doi: 10.1093/jnci/djr388. Epub 2011 Oct 4.
3
Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study.姑息治疗研究预后(PiPS)预测模型的开发,以改善晚期癌症的预后:前瞻性队列研究。
BMJ. 2011 Aug 25;343:d4920. doi: 10.1136/bmj.d4920.
4
Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.症状改善作为姑息治疗癌症患者生存的预后因素:一项初步研究。
Support Care Cancer. 2012 Jun;20(6):1221-6. doi: 10.1007/s00520-011-1207-8. Epub 2011 Jun 19.
5
Development and validation of a prognostic scale for use in patients with advanced cancer.一种用于晚期癌症患者的预后量表的开发与验证
Palliat Med. 2008 Sep;22(6):711-7. doi: 10.1177/0269216308095200.
6
[Approach to the methodology of classification and regression trees].[分类与回归树方法探讨]
Gac Sanit. 2008 Jan-Feb;22(1):65-72. doi: 10.1157/13115113.
7
The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study.B12/CRP指数作为晚期癌症患者的一个简单预后指标:一项验证性研究。
Ann Oncol. 2007 Aug;18(8):1395-9. doi: 10.1093/annonc/mdm138. Epub 2007 May 19.
8
Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study.乳酸脱氢酶作为晚期癌症患者生存时间的预后因素:一项初步研究。
Eur J Cancer. 2007 Apr;43(6):1051-9. doi: 10.1016/j.ejca.2007.01.031. Epub 2007 Mar 8.
9
Predicting prognosis in patients with advanced cancer.预测晚期癌症患者的预后。
Ann Oncol. 2007 Jun;18(6):971-6. doi: 10.1093/annonc/mdl343. Epub 2006 Oct 16.
10
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.晚期癌症患者的预后因素:循证临床建议——欧洲姑息治疗协会指导委员会的一项研究
J Clin Oncol. 2005 Sep 1;23(25):6240-8. doi: 10.1200/JCO.2005.06.866.

姑息性家庭护理团队开发的基于新症状的7天和30天生存预测工具。

New symptom-based predictive tool for survival at seven and thirty days developed by palliative home care teams.

作者信息

Nabal Maria, Bescos Mar, Barcons Miquel, Torrubia Pilar, Trujillano Javier, Requena Antonio

机构信息

1 Palliative Care Supportive Team, Hospital Universitario Arnau de Vilanova , Lleida, Institut Català de la Salut, IRB Lleida, Spain .

出版信息

J Palliat Med. 2014 Oct;17(10):1158-63. doi: 10.1089/jpm.2013.0630. Epub 2014 Jun 12.

DOI:10.1089/jpm.2013.0630
PMID:24922117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4195345/
Abstract

AIM

This study sought to develop models to predict survival at 7 and 30 days based on symptoms detected by palliative home care teams (PHCTs).

MATERIALS AND METHODS

This prospective analytic study included a 6-month recruitment period with patient monitoring until death or 180 days after recruitment. The inclusion criteria consisted of age greater than 18 years, advanced cancer, and treatment provided by participating PHCTs between April and July 2009. The study variables included death at 7 or 30 days, survival time, age, gender, place of residence, type of tumor and extension, presence of 11 signs and symptoms measured with a 0-3 Likert scale, functional and cognitive status, and use of a subcutaneous butterfly needle. The statistics applied included a descriptive analysis according to the percentage or mean±standard deviation. For symptom comparison between surviving and nonsurviving patients, the χ(2) test was used. Classification and regression tree (CART) methodology was used for model development. An internal validation system (cross-validation with 10 partitions) was used to ensure generalization of the models. The area under the receiver operating characteristics (ROC) curve was calculated (with a 95% confidence interval) to assess the validation of the models.

RESULTS

A total of 698 patients were included. The mean age of the patients was 73.7±12 years, and 60.3% were male. The most frequent type of neoplasm was digestive (37.6%). The mean Karnofsky score was 51.8±14, the patients' cognitive status according to the Pfeiffer test was 2.6±4 errors, and 8.3% of patients required a subcutaneous butterfly needle. Each model provided 8 decision rules with a probability assignment range between 2.2% and 99.1%. The model used to predict the probability of death at 7 days included the presence of anorexia and dysphagia and the level of consciousness, and this model produced areas under the curve (AUCs) of 0.88 (0.86-0.90) and 0.81 (0.79-0.83). The model used to predict the probability of death at 30 days included the presence of asthenia and anorexia and the level of consciousness, and this model produced AUCs of 0.78 (0.77-0.80) and 0.77 (0.75-0.79).

CONCLUSION

For patients with advanced cancer treated by PHCTs, the use of classification schemes and decision trees based on specific symptoms can help clinicians predict survival at 7 and 30 days.

摘要

目的

本研究旨在开发基于姑息家庭护理团队(PHCTs)所检测症状来预测7天和30天生存率的模型。

材料与方法

这项前瞻性分析研究包括为期6个月的招募期,并对患者进行监测直至死亡或招募后180天。纳入标准包括年龄大于18岁、晚期癌症以及2009年4月至7月期间由参与的PHCTs提供治疗。研究变量包括7天或30天内死亡、生存时间、年龄、性别、居住地点、肿瘤类型及分期、用0 - 3李克特量表测量的11种体征和症状的存在情况、功能和认知状态以及皮下蝶形针的使用。所应用的统计方法包括根据百分比或均值±标准差进行描述性分析。对于存活和未存活患者之间的症状比较,使用χ(2)检验。采用分类与回归树(CART)方法进行模型开发。使用内部验证系统(10折交叉验证)来确保模型的通用性。计算受试者操作特征(ROC)曲线下面积(95%置信区间)以评估模型的有效性。

结果

共纳入698例患者。患者的平均年龄为73.7±12岁,60.3%为男性。最常见的肿瘤类型是消化系统肿瘤(37.6%)。卡诺夫斯基评分的平均值为51.8±14,根据 Pfeiffer 测试患者的认知状态为2.6±4个错误,8.3%的患者需要皮下蝶形针。每个模型提供8条决策规则,概率赋值范围在2.2%至99.1%之间。用于预测7天内死亡概率的模型包括厌食、吞咽困难的存在情况以及意识水平,该模型产生的曲线下面积(AUCs)分别为0.88(0.86 - 0.90)和0.81(0.79 - 0.83)。用于预测30天内死亡概率的模型包括乏力、厌食的存在情况以及意识水平,该模型产生的AUCs分别为0.78(0.77 - 0.80)和0.77(0.75 - 0.79)。

结论

对于接受PHCTs治疗的晚期癌症患者,使用基于特定症状的分类方案和决策树可帮助临床医生预测7天和30天的生存率。